title: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
abstract: This is an updated version of the original Cochrane review published in 2005 on selective serotonin reuptake inhibitors (SSRIs) for preventing migraine and tension-type headache. The original review has been split in two parts and this review now only regards migraine prevention. Another updated review is under development to cover tension-type headache.Migraine is a common disorder. The chronic forms are associated with disability and have a high economic impact. In view of discoveries about the role of serotonin and other neurotransmitters in pain mechanisms, selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have been evaluated for the prevention of migraine.
  
  
  
  To determine the efficacy and tolerability of SSRIs and SNRIs compared to placebo and other active interventions in the prevention of episodic and chronic migraine in adults.
  
  
  
  For the original review, we searched MEDLINE (1966 to January 2004), EMBASE (1994 to May 2003), the Cochrane Central Register of Controlled Trials (CENTRAL 2003, Issue 4), and Headache Quarterly (1990 to 2003). For this update, we applied a revised search strategy to reflect the broader type of intervention (SSRIs and SNRIs). We searched CENTRAL (2014, Issue 10), MEDLINE (1946 to November 2014), EMBASE (1980 to November 2014), and PsycINFO (1987 to November 2014). We also checked the reference lists of retrieved articles and searched trial registries for ongoing trials.
  
  
  
  We included randomised controlled trials comparing SSRIs or SNRIs with any type of control intervention in participants 18 years and older of either sex with migraine.
  
  
  
  Two authors independently extracted data (migraine frequency, index, intensity, and duration; use of symptomatic/analgesic medication; days off work; quality of life; mood improvement; cost-effectiveness; and adverse events) and assessed the risk of bias of trials. The primary outcome of this updated review is migraine frequency.
  
  
  
  The original review included eight studies on migraine. Overall, we now include 11 studies on five SSRIs and one SNRI with a total of 585 participants. Six studies were placebo-controlled, four compared a SSRI or SNRI to amitriptyline, and one was a head-to-head comparison (escitalopram versus venlafaxine). Most studies had methodological or reporting shortcomings (or both): all studies were at unclear risk of selection and reporting bias. Follow-up rarely extended beyond three months. The lack of adequate power of most of the studies is also a major concern.Few studies explored the effect of SSRIs or SNRIs on migraine frequency, the primary endpoint. Two studies with unclear reporting compared SSRIs and SNRIs to placebo, suggesting a lack of evidence for a difference. Two studies compared SSRIs or SNRIs versus amitriptyline and found no evidence for a difference in terms of migraine frequency (standardised mean difference (SMD) 0.04, 95% confidence interval (CI) -0.72 to 0.80; I(2) = 72%), or other secondary outcomes such as migraine intensity and duration.SSRIs or SNRIs were generally more tolerable than tricyclics. However, the two groups did not differ in terms of the number of participants who withdrew due to adverse advents or for other reasons (one study, odds ratio (OR) 0.39, 95% CI 0.10 to 1.50 and OR 0.42, 95% CI 0.13 to 1.34).We did not find studies comparing SSRIs or SNRIs with pharmacological treatments other than antidepressants (e.g. antiepileptics and anti-hypertensives).
  
  
  
  Since the last version of this review, the new included studies have not added high quality evidence to support the use of SSRIs or venlafaxine as preventive drugs for migraine. There is no evidence to consider SSRIs or venlafaxine as more effective than placebo or amitriptyline in reducing migraine frequency, intensity, and duration over two to three months of treatment. No reliable information is available at longer-term follow-up. Our conclusion is that the use of SSRIs and SNRIs for migraine prophylaxis is not supported by evidence.
authors.affiliation: Laboratory of Regulatory Policies, IRCCS - Mario Negri Institute for Pharmacological Research, via G La Masa 19, Milan, Italy, 20156.
authors.forename: Rita
authors.initials: R
authors.lastname: Banzi
authors.forename: Cristina
authors.initials: C
authors.lastname: Cusi
authors.forename: Concetta
authors.initials: C
authors.lastname: Randazzo
authors.forename: Roberto
authors.initials: R
authors.lastname: Sterzi
authors.forename: Dario
authors.initials: D
authors.lastname: Tedesco
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Moja
mesh_terms: D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D000068760:Serotonin and Noradrenaline Reuptake Inhibitors / Q000627:therapeutic use*; D000069470:Venlafaxine Hydrochloride / Q000627:therapeutic use
chemical_list: D000639:Amitriptyline; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors; D000068760:Serotonin and Noradrenaline Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride
references.citation: Headache. 1992 Feb;32(2):101-4
references.pmid: 1551787
references.citation: Neurology. 1998 Jun;50(6):1741-5
references.pmid: 9633720
references.citation: Acta Neurol Scand. 1983 Oct;68(4):262-7
references.pmid: 6606930
references.citation: Arch Intern Med. 1999 Apr 26;159(8):813-8
references.pmid: 10219926
references.citation: QJM. 1996 Jan;89(1):77-84
references.pmid: 8730346
references.citation: Headache. 2002 Jun;42(6):510-4
references.pmid: 12167139
references.citation: Can J Neurol Sci. 2012 Mar;39(2 Suppl 2):S1-59
references.pmid: 22683887
references.citation: Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(8):20-3
references.pmid: 10983362
references.citation: Clin Neuropharmacol. 2009 Sep-Oct;32(5):254-8
references.pmid: 19667978
references.citation: Eur J Neurol. 2009 Sep;16(9):968-81
references.pmid: 19708964
references.citation: Value Health. 2013 Jan-Feb;16(1):31-8
references.pmid: 23337213
references.citation: BMJ. 2010 Oct 20;341:c5222
references.pmid: 20961988
references.citation: Trials. 2012 Aug 06;13:132
references.pmid: 22867278
references.citation: Lancet. 1990 Jan 20;335(8682):149-53
references.pmid: 1967441
references.citation: Acta Neurol Scand. 1981 Oct;64(4):280-8
references.pmid: 7032183
references.citation: JAMA. 2004 Jan 28;291(4):493-4
references.pmid: 14747508
references.citation: Cephalalgia. 1998 Jun;18(5):283-6
references.pmid: 9673809
references.citation: JAMA. 1992 Jan 1;267(1):64-9
references.pmid: 1727198
references.citation: Neuropsychobiology. 2004;50(4):322-8
references.pmid: 15539864
references.citation: Headache. 1999 Jan;39(1):28-32
references.pmid: 15613191
references.citation: Clin Neurol Neurosurg. 2004 Dec;107(1):44-8
references.pmid: 15567552
references.citation: Headache. 2009 Apr;49(4):498-508
references.pmid: 19245386
references.citation: Lancet. 2012 Dec 15;380(9859):2163-96
references.pmid: 23245607
references.citation: Neurology. 2012 Apr 24;78(17):1337-45
references.pmid: 22529202
references.citation: Headache. 1999 Nov-Dec;39(10):716-9
references.pmid: 11279947
references.citation: Headache. 2012 Jun;52(6):930-45
references.pmid: 22671714
references.citation: CNS Drugs. 2014 Jan;28(1):11-7
references.pmid: 24318669
references.citation: Neurology. 1996 Oct;47(4):871-5
references.pmid: 8857711
references.citation: Headache. 2001 Jul-Aug;41(7):646-57
references.pmid: 11554952
references.citation: Cephalalgia. 2010 May;30(5):599-609
references.pmid: 19614702
references.citation: BMJ. 1998 Oct 31;317(7167):1181-4
references.pmid: 9794850
references.citation: Neurology. 2004 May 11;62(9):1540-4
references.pmid: 15136678
references.citation: Acta Neurol Scand. 1986 Sep;74(3):235-9
references.pmid: 3538753
references.citation: Neurology. 2000 Oct 10;55(7):915-20
references.pmid: 11061244
references.citation: Cephalalgia. 2007 Nov;27(11):1293-300
references.pmid: 17970989
references.citation: Headache. 1994 Nov-Dec;34(10):587-9
references.pmid: 7843954
references.citation: Int J Epidemiol. 2002 Feb;31(1):140-9
references.pmid: 11914310
references.citation: J Headache Pain. 2012 Jul;13(5):361-78
references.pmid: 22644214
references.citation: Am J Med. 2001 Jul;111(1):54-63
references.pmid: 11448661
references.citation: Control Clin Trials. 1997 Dec;18(6):530-45; discussion 546-9
references.pmid: 9408716
references.citation: Headache. 1994 Sep;34(8):476-8
references.pmid: 7960733
references.citation: Cephalalgia. 2006 Dec;26(12):1434-42
references.pmid: 17116093
references.citation: J Epidemiol Community Health. 1997 Aug;51(4):354-8
references.pmid: 9328538
references.citation: Cephalalgia. 2012 Jan;32(1):6-38
references.pmid: 22384463
references.citation: Neurology. 2007 Jan 30;68(5):343-9
references.pmid: 17261680
references.citation: Cephalalgia. 1988;8 Suppl 7:1-96
references.pmid: 3048700
references.citation: Headache. 1994 Oct;34(9):497-502
references.pmid: 8002320
references.citation: Ann Intern Med. 2002 Nov 19;137(10):840-9
references.pmid: 12435222
references.citation: Headache. 2012 Jan;52(1):3-17
references.pmid: 22106869
references.citation: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002919
references.pmid: 16034880
references.citation: J Neurol. 2013 Aug;260(8):1960-9
references.pmid: 23132299
references.citation: Headache. 2005 Feb;45(2):144-52
references.pmid: 15705120
references.citation: BMJ. 2008 May 10;336(7652):1049-51
references.pmid: 18467413
references.citation: Neurology. 2004 Apr 27;62(8):1338-42
references.pmid: 15111671
references.citation: Cephalalgia. 2013 Jul;33(9):629-808
references.pmid: 23771276
references.citation: Cephalalgia. 2004;24 Suppl 1:9-160
references.pmid: 14979299
references.citation: Acta Neurol Scand. 1981 Dec;64(6):452-9
references.pmid: 6753446
references.citation: Clin J Pain. 1989 Jun;5(2):200-1
references.pmid: 2520405
references.citation: BMC Med. 2009 Nov 16;7:71
references.pmid: 19917094
references.citation: J Headache Pain. 2013 Jan 10;14:1
references.pmid: 23566305
references.citation: Eur J Neurol. 2012 May;19(5):703-11
references.pmid: 22136117
references.citation: Br J Psychiatry. 1999 Sep;175:217-23
references.pmid: 10645321
references.citation: JAMA. 2003 Mar 19;289(11):1430-3
references.pmid: 12636467
references.citation: Cephalalgia. 1999 Jun;19(5):531-2
references.pmid: 10403070